A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19).

ABSTRACT:

Background

Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the clinical efficacy of LQ on the treatment of COVID-19.

Methods

Seven databases (PubMed, EMBASE, CENTRAL, CNKI, VIP, CBM and Wanfang) were searched to include all appropriate clinical trials that explore the efficacy of LQ on the treatment of COVID-19.

Result

A total of 3 trials including 245 COVID-19 patients were eventually enrolled.Compared with the control group,the LQ group showed great significant difference on reducing the rate of clinical change to severe or critical

SUBMITTER: Zhuang J 

PROVIDER: S-EPMC8213518 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature